Addus HomeCare Corporation logo

Addus HomeCare Corporation (ADUS)

Market Closed
3 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
88. 49
-1.96
-2.1669%
$
1.67B Market Cap
- P/E Ratio
- Div Yield
242,780 Volume
- Eps
$ 90.45
Previous Close
Add Transaction
Day Range
87.95 90.94
Year Range
87.95 124.44
Want to track ADUS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
4 Stocks That Flaunt an Impressive Interest Coverage Ratio

4 Stocks That Flaunt an Impressive Interest Coverage Ratio

A company that is capable of generating earnings well above its interest expense can withstand financial hardship. HALO, LDOS, ATO & ADUS are sound enough to meet financial obligations.

Zacks | 1 year ago
Addus HomeCare (ADUS) Reports Q2 Earnings: What Key Metrics Have to Say

Addus HomeCare (ADUS) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Addus HomeCare (ADUS) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks | 1 year ago
Addus HomeCare (ADUS) Surpasses Q2 Earnings and Revenue Estimates

Addus HomeCare (ADUS) Surpasses Q2 Earnings and Revenue Estimates

Addus HomeCare (ADUS) came out with quarterly earnings of $1.35 per share, beating the Zacks Consensus Estimate of $1.20 per share. This compares to earnings of $1.07 per share a year ago.

Zacks | 1 year ago
ADUS vs. CHE: Which Stock Is the Better Value Option?

ADUS vs. CHE: Which Stock Is the Better Value Option?

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and Chemed (CHE). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks | 1 year ago
4 Stocks to Watch From a Challenging Outpatient Home Health Industry

4 Stocks to Watch From a Challenging Outpatient Home Health Industry

Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, EHC and ADUS are well-poised to gain.

Zacks | 1 year ago
Addus HomeCare (ADUS) Earnings Expected to Grow: Should You Buy?

Addus HomeCare (ADUS) Earnings Expected to Grow: Should You Buy?

Addus HomeCare (ADUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 year ago
3 Small-Cap Stocks Ready to Deliver Jumbo-Sized Gains

3 Small-Cap Stocks Ready to Deliver Jumbo-Sized Gains

On Wall Street, small-cap stocks often present unique opportunities for significant growth. These under-the-radar companies are typically not as well-known or widely covered by analysts as their large-cap counterparts.

Investorplace | 1 year ago